Insider Trading June 16, 2026 08:03 PM

Teradyne Executives and Market Dynamics

An analysis of recent insider activity, corporate developments, and valuation metrics for Teradyne, Inc. (NASDAQ: TER)

By Caleb Monroe
Share
Twitter Reddit Facebook LinkedIn
TER

Teradyne, Inc. (NASDAQ: TER) continues to navigate a complex market environment marked by significant insider transactions, strategic partnerships, and ongoing valuation debates. Recent data reveals a notable stock sale by CEO Gregory Smith, executed under a pre-existing trading plan, alongside broader corporate updates including a substantial defense contract and new technology collaborations. These events occur against a backdrop of substantial stock appreciation and mixed analyst perspectives on the company's current valuation relative to its fair value.

Teradyne Executives and Market Dynamics
TER
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • CEO Gregory Smith sold 4,000 shares worth $1.69 million under a Rule 10b5-1 plan, reducing his direct holdings to approximately 120,469 shares.
  • Teradyne secured a $139.9 million defense contract for diagnostic test equipment and launched a new AI/data center test solution in partnership with Tokyo Electron.
  • Analyst perspectives diverge, with InvestingPro flagging the stock as overvalued at a 77.37 P/E ratio, while Aletheia highlights growth potential in GPU and co-packaged optics sectors.

Gregory Stephen Smith, who serves as the President and Chief Executive Officer of Teradyne, Inc. (NASDAQ: TER), executed a sale of 4,000 shares of the company's common stock on June 15, 2026. The transaction, which totaled $1,692,120, was processed at a per-share price of $423.03. This valuation sits in close proximity to the stock's 52-week high of $437.77. The sale follows a period of remarkable equity performance for Teradyne, with shares experiencing a 375% surge over the trailing twelve months, according to data from InvestingPro. Post-transaction, Mr. Smith's direct holding in Teradyne common stock stands at 120,469.5729 shares.

The reported sale was conducted in accordance with a Rule 10b5-1 sales plan, which Mr. Smith initially adopted on February 12, 2026. This automated trading mechanism is designed to facilitate the execution of stock transactions without direct daily intervention, often utilized by corporate insiders to manage equity holdings systematically.

In broader corporate developments, Teradyne has secured a significant contract valued at $139.9 million from the U.S. Department of War. This agreement involves the provision of versatile diagnostic automatic test station kits. The operational scope includes the assembly of standardized test equipment and components at Robins Air Force Base in Georgia. Additionally, the company has introduced a new integrated test cell solution designed for AI and data center applications. This offering is the result of a collaboration with Tokyo Electron, combining Teradyne's UltraFLEXplus platform with Tokyo Electron's Prexa SDP to facilitate advanced device screening.

Corporate governance updates from the 2026 annual meeting indicate that Teradyne's shareholders elected all nominated directors and approved key proposals. Furthermore, the company has declared a quarterly cash dividend of $0.13 per share. This dividend is payable on June 12, 2026, to shareholders of record as of May 21, 2026.

Market analysis presents a mixed view of Teradyne's current standing. InvestingPro analysis suggests the stock is currently overvalued relative to its Fair Value, citing a P/E ratio of 77.37. Conversely, Aletheia, an analyst firm, has identified potential growth opportunities for Teradyne, particularly within the GPU and co-packaged optics technology sectors. The stock's recent trading activity reflects volatility, with closing prices recorded at 409.40, down 23.01 or 5.32%, while after-hours trading showed a slight increase to 410.00, up 0.65 or 0.16%.

Risks

  • Valuation concerns are highlighted by InvestingPro, which indicates the stock is overvalued relative to its Fair Value, potentially impacting investor sentiment and market perception.
  • The reliance on automated trading plans like Rule 10b5-1 for insider transactions may limit the ability to react swiftly to sudden market changes, though it ensures compliance with trading regulations.
  • Market volatility is evident in recent trading data, with the stock experiencing a 5.32% decline in closing prices, reflecting potential uncertainty in short-term equity performance.

More from Insider Trading

Pagaya President Sanjiv Das Executes Share Transactions Amid Strategic Shift Jun 16, 2026 Pagaya Director Tami Rosen Sells $92,202 in PGY Shares Jun 16, 2026 Ambarella Executive Reduces Stake Amid Mixed Analyst Outlook Jun 16, 2026 Vera Bradley Director Andrew Meslow Acquires $92,973 in Shares Amid Strategic Retail Expansion Jun 16, 2026 Dentsply Sirona Director Clyde Hosein Acquires $64,902 in Company Stock Jun 16, 2026